Abstract
Defects in mitochondrial function have been shown to participate in the induction of neuronal cell injury. The aim of the present study was to assess the preventive effect of licorice compounds glycyrrhizin and 18β-glycyrrhetinic acid against the toxicity of parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP+) in relation to the mitochondria-mediated cell death process and role of oxidative stress. MPP+ induced the nuclear damage, the changes in the mitochondrial membrane permeability, leading to the cytochrome c release and caspase-3 activation, the formation of reactive oxygen species, and the depletion of glutathione (GSH) in differentiated PC12 cells. Glycyrrhizin up to 100 μM significantly attenuated cell death and depletion of GSH due to MPP+ concentration-dependently. Meanwhile, 18β-glycyrrhetinic acid showed a maximal inhibitory effect at 10 μM; beyond this concentration, the inhibitory effect declined. The protective effect of licorice compounds was also detected in the rotenone-treated PC12 cells. Glycyrrhizin and 18β-glycyrrhetinic acid prevented the MPP+-induced formation of the mitochondrial permeability transition. The results show that both glycyrrhizin and a metabolite, 18β-glycyrrhetinic acid, exhibit a depressant effect against the MPP+ toxicity. Glycyrrhizin and 18β-glycyrrhetinic acid may prevent the cytotoxicity of MPP+ by suppressing the mitochondrial permeability transition formation. The preventive effect seems to be ascribed to the inhibitory effect on the formation of reactive oxygen species and depletion of GSH.
Footnotes
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
doi:10.1124/jpet.107.119602.
-
ABBREVIATIONS: ROS, reactive oxygen species; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+, 1-methyl-4-phenylpyridinium iodide; GL, glycyrrhizin; GA, 18β-glycyrrhetinic acid; carboxy-PTIO, 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide; Mn-TBAP, Mn(III) tetrakis(4-benzoic acid)porphyrin chloride; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; DiOC6(3), 3,3′-dihexyloxacarbocyanine iodide; DCFH2-DA, 2′,7′-dichlorofluorescein diacetate; PBS, phosphate-buffered saline; FBS, fetal bovine serum; GSH, glutathione; ELISA, enzyme-linked immunosorbent assay; DCF, fluorescent 2′,7′-dichlorofluorescein.
- Received January 7, 2007.
- Accepted February 16, 2007.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|